November 2014 – Valence Newsletter

  • Chemical company EBITDA trading multiples indicate high-end specialty chemicals now most fairly valued area
  • M&A advisory boutiques continue to gain ground on the majors and recent court rulings regarding conflicts of interest also likely to favour independents in the future
  • Chemical sectors linked to the North American economy continue to outperform the industry as highlighted by the Valence Indices
  • More than 10 $1bn+ transactions in the last six months coupled with strong M&A volumes in Q2/Q3 are expected to result in 2014 being one of the most active in the last 15 years

Download Chemical M&A Review Nov 2014